SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003771
Filing Date
2018-03-23
Accepted
2018-03-22 19:34:58
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1123026
2 ex23-1.htm EX-23.1 4547
3 ex31-1.htm EX-31.1 8397
4 ex31-2.htm EX-31.2 8583
5 ex32.htm EX-32 4298
  Complete submission text file 0001493152-18-003771.txt   4782730

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pvct-20171231.xml EX-101.INS 678748
7 XBRL SCHEMA FILE pvct-20171231.xsd EX-101.SCH 62638
8 XBRL CALCULATION FILE pvct-20171231_cal.xml EX-101.CAL 56234
9 XBRL DEFINITION FILE pvct-20171231_def.xml EX-101.DEF 234087
10 XBRL LABEL FILE pvct-20171231_lab.xml EX-101.LAB 425089
11 XBRL PRESENTATION FILE pvct-20171231_pre.xml EX-101.PRE 319634
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36457 | Film No.: 18708058
SIC: 2834 Pharmaceutical Preparations